Finance

Lists
Q1 2027 earnings • released • EPS beat +၆.၅၈% • Revenue beat +၆.၀၁%
See results
GLAND:NSE
Gland Pharma Ltd
၂,၉၆၆.၀၀ ₹
+၂.၅၉%
(+၇၄.၈၀) 1D
ဩ ၁၃, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAND...
Open
၂,၈၉၁.၁၀ ₹
High
၂,၉၇၅.၀၀ ₹
Low
၂,၈၂၅.၅၀ ₹
Mkt. cap
ဋေ ၄.၈၉ သ
Avg. vol.
၀.၀၀
Volume
၇.၉၃ သိန်း
Dividend
၀.၆၇%
Quarterly dividend
၅.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဩ ၁၁
P/E ratio
၄၃.၃၇
52-wk high
၂,၉၈၈.၄၀ ₹
52-wk low
၁,၅၇၃.၆၀ ₹
EPS
၆၈.၃၉ ₹
No. of employees
၄ ထောင်
Open
၂,၈၉၁.၁၀ ₹
High
၂,၉၇၅.၀၀ ₹
Low
၂,၈၂၅.၅၀ ₹
Mkt. cap
ဋေ ၄.၈၉ သ
Avg. vol.
၀.၀၀
Volume
၇.၉၃ သိန်း
Dividend
၀.၆၇%
Quarterly dividend
၅.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဩ ၁၁
P/E ratio
၄၃.၃၇
52-wk high
၂,၉၈၈.၄၀ ₹
52-wk low
၁,၅၇၃.၆၀ ₹
EPS
၆၈.၃၉ ₹
No. of employees
၄ ထောင်
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Earnings Beat: Gland Pharma Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၃ ရက်
Gland Pharma Posts Q1 FY27 Earnings Call Recording Online
TradingView
TradingView
·
ပြီးခဲ့သည့် ၃ ရက်
GLAND: Q1 FY 2027 delivered robust growth, with 20% higher revenue and strong CDMO momentum
About Gland Pharma Ltd
CEOShyamakant Giri
Employees၄.၃၃ ထောင်
Founded၁၉၇၈
Headquarters-
Sector-
Websiteglandpharma.com
Last report
၂၀၂၆ ဩ ၁၀
Fiscal period
Q1 2027
EPS / Est. (INR)
၁၉.၂၂ ₹ / ၁၈.၀၃ ₹
+၆.၅၈%beat
Revenue / Est. (INR)
ဋေ ၁.၈၆ ထ / ဋေ ၁.၇၆ ထ
+၆.၀၁%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၄၉ ထ
ဋေ ၁.၇၀ ထ
ဋေ ၁.၇၄ ထ
ဋေ ၁.၈၆ ထ
Cost of goods sold
၆၀၃.၉၈ ဋေ
၆၃၀.၆၆ ဋေ
၈၃၁.၉၈ ဋေ
၆၈၀.၂၁ ဋေ
Cost of revenue
၆၀၃.၉၈ ဋေ
၆၃၀.၆၆ ဋေ
၈၃၁.၉၈ ဋေ
၆၈၀.၂၁ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၈၅.၀၃ ဋေ
၄၂၄.၂၀ ဋေ
၄၂၅.၅၄ ဋေ
၄၄၄.၀၀ ဋေ
Operating expense
၆၇၅.၃၂ ဋေ
၇၃၇.၄၇ ဋေ
၅၂၁.၇၂ ဋေ
၇၄၁.၉၆ ဋေ
Total operating expenses
ဋေ ၁.၂၈ ထ
ဋေ ၁.၃၇ ထ
ဋေ ၁.၃၅ ထ
ဋေ ၁.၄၂ ထ
Operating income
၂၀၇.၅၈ ဋေ
၃၂၇.၂၃ ဋေ
၃၈၉.၀၉ ဋေ
၄၃၉.၃၄ ဋေ
Other non operating income
၈၄.၁၆ ကုဋေ
၆၃.၁၇ ကုဋေ
-၁၇၈.၆၆ ဋေ
-
EBT including unusual items
၂၈၃.၉၂ ဋေ
၃၆၂.၁၃ ဋေ
၅၀၅.၈၀ ဋေ
၄၃၄.၉၈ ဋေ
EBT excluding unusual items
၂၈၃.၉၂ ဋေ
၃၈၆.၄၇ ဋေ
၅၀၂.၁၁ ဋေ
၄၃၄.၉၈ ဋေ
Income tax expense
၁၀၀.၂၃ ဋေ
၁၀၀.၆၅ ဋေ
၁၃၉.၁၂ ဋေ
၁၁၈.၀၂ ဋေ
Effective tax rate
၃၅.၃၀%
၂၇.၇၉%
၂၇.၅၁%
၂၇.၁၃%
Other operating expenses
၁၈၃.၉၈ ဋေ
၂၀၅.၆၃ ဋေ
-၁၃.၀၂ ကုဋေ
၁၈၆.၇၀ ဋေ
Net income
၁၈၃.၆၈ ဋေ
၂၆၁.၄၈ ဋေ
၃၆၆.၆၈ ဋေ
၃၁၆.၉၆ ဋေ
Net profit margin
၁၂.၃၅%
၁၅.၄၂%
၂၁.၀၄%
၁၇.၀၃%
Earnings per share
၁၁.၁၅
၁၆.၉၈
၂၂.၂၃
၁၉.၂၂
Interest and investment income
-
-
၂၀၅.၅၄ ဋေ
-
Interest expense
-၇.၈၂ ကုဋေ
-၃.၉၃ ကုဋေ
-၆.၃၁ ကုဋေ
-၄.၃၆ ကုဋေ
Net interest expenses
-၇.၈၂ ကုဋေ
-၃.၉၃ ကုဋေ
၁၉၉.၂၄ ဋေ
-၄.၃၆ ကုဋေ
Depreciation and amortization charges
၁၀၆.၃၁ ဋေ
၁၀၇.၆၄ ဋေ
၁၀၈.၆၆ ဋေ
၁၁၁.၂၆ ဋေ
EBITDA
၃၁၁.၂၆ ဋေ
၄၁၇.၀၅ ဋေ
၄၉၀.၇၂ ဋေ
၅၄၀.၉၇ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ